Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86885538

Enrollment

100

Registered

2007-01-16

Start date

2007-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related infections Infections and Infestations Catheter-related infections

Interventions

Taurolidine-citrate vs heparin as catheter lock solutions

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients with newly implanted central venous catheters

Exclusion criteria

Exclusion criteria: Bacteremia/sepsis ongoing; allergy against heparin or taurolidine

Design outcomes

Primary

Measure	Time frame
Bacterial growth/biofilm formation in removed catheters	—

Secondary

Measure	Time frame
Catheter-related infections, catheter occlusions	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026